1 min readMumbaiMay 9, 2016 12:17 PM IST
First published on: May 9, 2016 at 12:17 PM IST
Drug firm Wockhardt’s script on Monday fell by over 3 per cent over disappointment on the company’s March quarter results.
The company had announced its quarterly results on Friday post market hours.
Shares of the company declined 3.27 per cent to Rs 906 on BSE.
At NSE, it went down by 3.41 per cent to Rs 905.50.
Wockhardt on Friday reported a 25.88 per cent rise in consolidated net profit to Rs 42.90 crore for the quarter ended March 31.
The company had posted a net profit of Rs 34.08 crore for the corresponding period of the previous fiscal, Wockhardt had said in a BSE filing.
Consolidated net sales, however, stood at Rs 1,013.36 crore for the quarter under review as against Rs 1,079.14 crore a year ago.
For the full fiscal, the consolidated net profit declined to Rs 325.66 crore as against Rs 404.91 crore for the previous fiscal.
Consolidated net sales stood at Rs 4,461.43 crore for the just-included fiscal year. It was Rs 4,481.54 crore in the year-ago period.
PTI
Share
